Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease
Mengyue Niu, Fanpeng Zhao, Karina S. Bondelid, et al.
Aging Cell (2021) Vol. 20, Iss. 5
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Understanding the contributions of VPS35 and the retromer in neurodegenerative disease
Erin T. Williams, Xi Chen, P. Anthony Otero, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105768-105768
Open Access | Times Cited: 33
Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting
Prajakta Teli, Vaijayanti Kale, Anuradha Vaidya
Cell and Tissue Research (2023) Vol. 394, Iss. 1, pp. 75-91
Closed Access | Times Cited: 19
Retromer-dependent lysosomal stress in Parkinson's disease
Dario R. Alessi, Peter J. Cullen, Mark Cookson, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 8
Immune cell metabolic dysfunction in Parkinson’s disease
Julian R Mark, Malú G. Tansey
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition
Anusha Kamesh, Chelsie Kadgien, Naila Kuhlmann, et al.
Research Square (Research Square) (2025)
Closed Access
Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition
Anusha Kamesh, Chelsie Kadgien, Naila Kuhlmann, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Gene-modified animal models of Parkinson's disease
Yong Peng, Dazhi Jiang, Shunyu Yao, et al.
Experimental Neurology (2025) Vol. 390, pp. 115287-115287
Closed Access
Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
Rémi Kinet, Benjamin Dehay
Cells (2023) Vol. 12, Iss. 4, pp. 621-621
Open Access | Times Cited: 9
Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice
Mengfei Bu, Jordan Follett, Isaac Deng, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Endosomal Recycling Defects and Neurodevelopmental Disorders
Shinji Saitoh
Cells (2022) Vol. 11, Iss. 1, pp. 148-148
Open Access | Times Cited: 13
The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson’s disease
Suzhen Lin, Yimei Shu, Ruinan Shen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition
Chelsie Kadgien, Anusha Kamesh, Austen J. Milnerwood
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Gestational Diabetes Mellitus-Associated Hyperglycemia Impairs Glucose Transporter 3 Trafficking in Trophoblasts Through the Downregulation of AMP-Activated Protein Kinase
Li Zhang, Xinyang Yu, Yue Wu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Mechanisms of VPS35-mediated neurodegeneration in Parkinson's disease
Dorian Sargent, Darren J. Moore
International review of movement disorders (2021), pp. 221-244
Open Access | Times Cited: 14
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
Xi Chen, Elpida Tsika, Nathan Levine, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenues
Cíntia Barros Santos-Rebouças, Juliana Cordovil Cotrin, Gilson Costa dos Santos
Mechanisms of Ageing and Development (2023) Vol. 216, pp. 111875-111875
Closed Access | Times Cited: 5
Progress in Parkinson's disease animal models of genetic defects: Characteristics and application
Chutian Zhang, Shiya Chen, Xiyu Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113768-113768
Open Access | Times Cited: 7
VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress
Anika Wu, Daehoon Lee, Wen-Cheng Xiong
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 701-712
Open Access | Times Cited: 1
Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathway
Yi Huang, Heng Huang, Leping Zhou, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 22, pp. 3886-3896
Closed Access | Times Cited: 6
Aging, Parkinson’s Disease, and Models: What Are the Challenges?
Ilaria Bellantuono, Heather Mortiboys, Emily M. Rocha, et al.
(2023) Vol. 1, Iss. 1, pp. 20230010-20230010
Open Access | Times Cited: 3
Rodent models based on endolysosomal genes involved in Parkinson's disease
María Sanchiz-Calvo, Eduard Bentea, Veerle Baekelandt
Current Opinion in Neurobiology (2021) Vol. 72, pp. 55-62
Open Access | Times Cited: 6
Beware of Misdelivery: Multifaceted Role of Retromer Transport in Neurodegenerative Diseases
Shun Yoshida, Takafumi Hasegawa
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 4
Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies
Emma E. Russo, Lola E. Zovko, Reza Nazari, et al.
eNeuro (2023) Vol. 10, Iss. 5, pp. ENEURO.0341-22.2023
Open Access | Times Cited: 2
Impaired neurogenesis and synaptogenesis in iPSC-derived Parkinson’s patient cortical neurons with D620N VPS35 mutation
Ute Scheller, ChoongKu Lee, Philip Seibler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Endosomal traffic disorders: a driving force behind neurodegenerative diseases
Jianru Dong, Winnie Tong, Mingyan Liu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top